微博
加入微博一起分享新鲜事
登录
|
注册
140
Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central ret https://eprints.soton.ac.uk/453451/
请登录并选择要私信的好友
300
Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central ret https://eprints.soton.ac.uk/453451/
赞一下这个内容
公开
分享
获取分享按钮
正在发布微博,请稍候